Spinal 2-Chloroprocaine: A Dose-Ranging Study and the Effect of Added Epinephrine

Anesthesia and Analgesia

Volumn 98, Issue 1, 2004, Pages 81-88

  Smith, Kristin N ^a   Kopacz, Dan J ^a   McDonald, Susan B ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIOXIDANT; CHLOROPROCAINE; LIDOCAINE; PRESERVATIVE;

ADULT; ANESTHESIA LEVEL; ANOREXIA; ARTHRALGIA; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG FORMULATION; DRUG POTENTIATION; DRUG SAFETY; FEMALE; FLU LIKE SYNDROME; HEADACHE; HUMAN; HUMAN EXPERIMENT; HYPOTENSION; MALAISE; MALE; MYALGIA; NERVE BLOCK; NORMAL HUMAN; NOSE CONGESTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPINAL ANESTHESIA;

EID: 0347363661     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000093361.48458.6E     Document Type: Article

References (17)

1. Pollock JE. Transient neurologic symptoms: etiology, risk factors, and management. Reg Anesth Pain Med 2002;27:581-6.
2. Le Truong HH, Girard M, Drolet P, et al. Spinal anesthesia: a comparison of procaine and lidocaine. Can J Anaesth 2001;48:470-3.
3. Hodgson PS, Liu SS, Batra MS, et al. Procaine compared with lidocaine for incidence of transient neurologic symptoms. Reg Anesth Pain Med 2000;25:218-22.
4. Bergeron L, Girard M, Drolet P, et al. Spinal procaine with and without epinephrine and its relation to transient radicular irritation. Can J Anaesth 1999;46:846-9.
5. Foldes FF, McNall PG. 2-chloroprocaine: a new local anesthetic agent. Anesthesiology 1952;13:287-96.
6. Winnie AP, Nadar AM. Santayana's prophecy fulfilled. Reg Anesth Pain Med 2001;26:558-64.
7. Ravindran RS, Bond VK, Tasch MD, et al. Prolonged neural blockade following regional anesthesia with 2-chloroprocaine. Anesth Analg 1980;59:447-51.
8. Reisner LS, Hochman BN, Plumer MH. Persistent neurologic deficit and adhesive arachnoiditis following intrathecal 2-chloroprocaine. Anesth Analg 1980;59:452-4.
9. Moore DC, Spierdijk J, van Kleef JD, et al. Chloroprocaine toxicity: four additional cases. Anesth Analg 1982;61:158-9.
10. Gissen AJ, Datta S, Lambert D. The chloroprocaine controversy II: is chloroprocaine neurotoxic? Reg Anesth 1984;9:135-45.
11. Wang BC, Hillman DE, Spielholz NI. Chronic neurological deficits and Nesacaine-CE: an effect of the anesthetic, 2-chloroprocaine, or the antioxidant, sodium bisulfite? Anesth Analg 1984;63:445-7.
12. Petersen-Felix S, Zbinden AM, Fischer M, et al. Isoflurane minimum alveolar concentration decreases during anesthesia and surgery. Anesthesiology 1993;79:959-65.
13. Chiu AA, Liu SS, Carpenter RL, et al. The effects of epinephrine on lidocaine spinal anesthesia: a cross-over study. Anesth Analg 1995;80:735-9.
14. Liu SS, Ware PD, Allen HW, et al. Dose-response characteristics of spinal bupivacaine in volunteers: clinical implications for ambulatory anesthesia. Anesthesiology 1996;85:729-36.
15. Kito K, Kato H, Sibata M, et al. The effect of varied doses of epinephrine on duration of lidocame spinal anesthesia in the thoracic and lumbosacral dermatomes. Anesth Analg 1998;86:1018-22.
16. Moore JM, Liu SS, Pollock JE, et al. The effect of epinephrine on small-dose hyperbaric bupivacaine spinal anesthesia: clinical implications for ambulatory surgery. Anesth Analg 1998;86:973-7.
17. Vaida GT, Moss P, Capan LM, et al. Prolongation of lidocaine spinal anesthesia with phenylephrine. Anesth Analg 1986;65:781-5.